ACG Clinical Guideline: Gastroparesis
- PMID: 35926490
- PMCID: PMC9373497
- DOI: 10.14309/ajg.0000000000001874
ACG Clinical Guideline: Gastroparesis
Abstract
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with objective evidence of delayed gastric emptying in the absence of mechanical obstruction in the gastric outflow. This condition is increasingly encountered in clinical practice. These guidelines summarize perspectives on the risk factors, diagnosis, and management of gastroparesis in adults (including dietary, pharmacological, device, and interventions directed at the pylorus), and they represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation process. When the evidence was not appropriate for Grading of Recommendations, Assessment, Development, and Evaluation, we used expert consensus to develop key concept statements. These guidelines should be considered as preferred but are not the only approaches to these conditions.
Copyright © 2022 by The American College of Gastroenterology.
Conflict of interest statement
Potential conflicts of interest:
MC: Single-center research studies: Allergan, Takeda, and Vanda; Consulting with compensation to his employer: Takeda, Alpha Sigma Wasserman
TA: Investigator: Censa, Clndome, Vanda, Allergan, Neurogastrix; Consultant: Censa, Nuvaira, Takeda, Medtronic; Speaker: Takeda, Medtronic; Reviewer: UpToDate; Writer: Med Study; Editorial:
BK: Clinical trials with Takeda, Vanda, Alpha Sigma Wasserman, GSK; Consulting with Takeda, Cindome, Neurogastrix; Speaking for Medtronic
LN: Investigator: Allergan, Vanda; Consultant: Abbvie, Ironwood, Alnylam, Eli Lilly, Gemelli, Neurogastrx, Pendulum, Phathom, RosVivo, Salix, Takeda. Scientific Advisory Board: Gemelli, RosVivo
VMV: Nothing to disclose
JP: Nothing to disclose
KG: Nothing to disclose
RY: Consultant through Institutional Agreement: Medtronic, Ironwood Pharmaceuticals, Diversatek, StatLinkMD; Research support: Ironwood Pharmaceuticals; Advisory Board: Phathom Pharmaceuticals; RJS Mediagnostix
Figures
Similar articles
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.United European Gastroenterol J. 2021 Apr;9(3):287-306. doi: 10.1002/ueg2.12060. United European Gastroenterol J. 2021. PMID: 33939892 Free PMC article.
-
Emerging strategies for the treatment of gastroparesis.Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):817-25. doi: 10.1586/17474124.2016.1150175. Epub 2016 Mar 4. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26840446 Review.
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.Neurogastroenterol Motil. 2021 Aug;33(8):e14237. doi: 10.1111/nmo.14237. Neurogastroenterol Motil. 2021. PMID: 34399024
-
2023 update on the clinical management of gastroparesis.Expert Rev Gastroenterol Hepatol. 2023 May;17(5):431-441. doi: 10.1080/17474124.2023.2196404. Epub 2023 Mar 29. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36970885 Review.
-
Gastroparesis.Gastroenterology. 2022 Jan;162(1):68-87.e1. doi: 10.1053/j.gastro.2021.10.028. Epub 2021 Oct 27. Gastroenterology. 2022. PMID: 34717924 Free PMC article. Review.
Cited by
-
Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review.J Clin Med. 2024 Sep 22;13(18):5627. doi: 10.3390/jcm13185627. J Clin Med. 2024. PMID: 39337114 Free PMC article. Review.
-
Medication reconciliation enhances the accuracy of gastric emptying scintigraphy.EJNMMI Radiopharm Chem. 2024 Sep 26;9(1):68. doi: 10.1186/s41181-024-00299-3. EJNMMI Radiopharm Chem. 2024. PMID: 39325280 Free PMC article.
-
Predicting Response to Neuromodulators or Prokinetics in Patients With Suspected Gastroparesis Using Machine Learning: The "BMI, Infectious Prodrome, Delayed GES, and No Diabetes" Model.Clin Transl Gastroenterol. 2024 Sep 1;15(9):e1. doi: 10.14309/ctg.0000000000000743. Clin Transl Gastroenterol. 2024. PMID: 39320959 Free PMC article.
-
Establishment of predictive models and determinants of preoperative gastric retention in endoscopic retrograde cholangiopancreatography.World J Gastrointest Surg. 2024 Aug 27;16(8):2574-2582. doi: 10.4240/wjgs.v16.i8.2574. World J Gastrointest Surg. 2024. PMID: 39220084 Free PMC article.
-
Postoperative delayed gastric emptying: may gut microbiota play a role?Front Cell Infect Microbiol. 2024 Aug 13;14:1449530. doi: 10.3389/fcimb.2024.1449530. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39193506 Free PMC article. Review.
References
-
- Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004;127:1592–1622. - PubMed
-
- Nishiwaki S, Kurobe T, Baba A, et al. Prognostic outcomes after direct percutaneous endoscopic jejunostomy in elderly patients: comparison with percutaneous endoscopic gastrostomy. Gastrointest Endosc 2021;94:48–56. - PubMed
-
- Tan Y-W, Yan Ting Chua A, Ng Yin K, et al. Optimal management of gastrojejunal tube in the ENFit era - Interventions that changed practice. J Pediatr Surg 2021; 6:1430–1435. - PubMed
-
- Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103:416–23 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
